| Original language | English (US) |
|---|---|
| Pages (from-to) | 308-323 |
| Number of pages | 16 |
| Journal | American journal of obstetrics and gynecology |
| Volume | 220 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2019 |
All Science Journal Classification (ASJC) codes
- Obstetrics and Gynecology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway : A Report From the American Gastroenterological Association IBD Parenthood Project Working Group. / Mahadevan, Uma; Robinson, Christopher; Bernasko, Nana; Boland, Brigid; Chambers, Christina; Dubinsky, Marla; Friedman, Sonia; Kane, Sunanda; Manthey, Jacob; Sauberan, Jason; Stone, Joanne; Jain, Rajeev.
In: American journal of obstetrics and gynecology, Vol. 220, No. 4, 04.2019, p. 308-323.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway
T2 - A Report From the American Gastroenterological Association IBD Parenthood Project Working Group
AU - Mahadevan, Uma
AU - Robinson, Christopher
AU - Bernasko, Nana
AU - Boland, Brigid
AU - Chambers, Christina
AU - Dubinsky, Marla
AU - Friedman, Sonia
AU - Kane, Sunanda
AU - Manthey, Jacob
AU - Sauberan, Jason
AU - Stone, Joanne
AU - Jain, Rajeev
N1 - Funding Information: Conflicts of interest: These authors disclose the following: Uma Mahadevan: Consulting for Janssen, AbbVie, Pfizer, Takeda, Celgene, Lilly, and Samsung. Christopher Robinson: Board of Directors, Society for Maternal Fetal Medicine; Associate Editor American Journal of Perinatology; Media Editor American Journal of Obstetrics and Gynecology. Nana Bernasko: Pfizer and Takeda Advisory Board. Brigid Boland: Consultant for AbbVie and Prometheus Labs. Christina Chambers: Research funding from AbbVie, Amgen Inc, Astra Zeneca, Apotex, Barr Laboratories, Inc, Bristol-Myers Squibb, Celgene, Gerber Foundation, GlaxoSmithKline, Janssen Pharmaceutical, Kali Laboratories Inc, Pfizer Inc, Hoffman La Roche-Genetech, Sandoz Pharmaceuticals, Genzyme Sanofi-Aventis, Regeneron, Sequirus, Takeda, Teva Pharmaceutical Industries, and UCB. Marla Dubinsky: Consultant for AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly, Genentech, Janssen, Pfizer, Prometheus, Salix, Shire, Takeda, and UCB. Sunanda Kane: Consultant for AbbVie, Merck, Spherix Health, and Seres. Rajeev Jain: American Board of Internal Medicine (ABIM) member (no ABIM questions are shared in the article) and research with AbbVie, Genetech, Gilead, Janssen, and Takeda. The remaining authors disclose no conflicts. Funding Information: AGA's IBD Parenthood Project is funded through support from UCB, a global biopharmaceutical company.
PY - 2019/4
Y1 - 2019/4
UR - http://www.scopus.com/inward/record.url?scp=85063642233&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063642233&partnerID=8YFLogxK
U2 - 10.1016/j.ajog.2019.02.027
DO - 10.1016/j.ajog.2019.02.027
M3 - Article
C2 - 30948039
AN - SCOPUS:85063642233
VL - 220
SP - 308
EP - 323
JO - American Journal of Obstetrics and Gynecology
JF - American Journal of Obstetrics and Gynecology
SN - 0002-9378
IS - 4
ER -